{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-077064","form_type":"8-K","ticker":"TCRT","cik":"0001107421","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2025-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.537349+00:00","generated_at":"2026-05-20T13:08:41.124926+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Alaunos Therapeutics enters $25M equity purchase agreement with Mast Hill Fund","bullets":["Mast Hill commits to buy up to $25M of common stock over 24 months at Company's discretion.","Company issued warrant to Mast Hill for 79,900 shares at $4.00 exercise price, 5-year term.","Minimum put $5K, max $500K per put or 20% of 5-day avg trading volume.","Shares subject to 4.99% beneficial ownership cap and Nasdaq 19.99% exchange cap unless stockholder approval.","Registration rights agreement requires filing registration statement within 60 days."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-077064","json":"https://secwatch.observer/filing/0000950170-25-077064.json","markdown":"https://secwatch.observer/filing/0000950170-25-077064.md","text":"https://secwatch.observer/filing/0000950170-25-077064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025077064/0000950170-25-077064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025077064/tcrt-20250519.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T13:08:41.124926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}